ZVRA
NASDAQ
$12.03
Zevra Therapeutics Inc (ZVRA)
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company is headquartered in Celebration, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $27.89 (+131.84%)
Market Cap
$766M
Revenue 5Y CAGR
+39.30%
Profit Margin
101.6%
P/E Ratio
5.89
Price Chart
Valuation
Market Cap$766M
P/E5.89
Forward P/E11.93
PEG10.67
P/S6.26
P/B3.75
Profitability
Total Revenue (TTM)$122M
Gross Profit (TTM)$105M
EBITDA-$2.66M
Profit Margin101.6%
Operating Margin24.4%
EPS$2.20
Financial Health
Free Cash Flow Yield1.56%
Growth & Risk
Revenue 5Y CAGR+39.30%
Beta (5Y)0.64
Sharpe Ratio0.16